<TEXT>&#2;<DATELINE>2004</DATELINE><TITLE>The SARS-CoV S glycoprotein</TITLE><BODY>The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. Recent rapid advances in our knowledge of the structure and function of this protein have lead to the development of a number of candidate vaccine immunogens and SARS-CoV entry inhibitors.&#3;</BODY></TEXT>